Neurocrine BiosciencesNBIX 
$119.85-2.01%24h
-2.01%24h
Global rank1381
Market cap$11.78B
Change 7d-4.27%
YTD Performance-7.95%
SP500 benchmarkUnderperform
P/E0
P/S6.24
Revenue$1.89B
Earnings$249.70M
Dividend yield-
Main Sector
Healthcare
Neurocrine Biosciences NBIX Operating Margins
Operating Margin in 2022: 0.21%
According to Neurocrine Biosciences latest financial reports the company has an operating margin of 0.21%, an increase of 25.08% to 2022. At the end of 2022 company had an operating margin of 0.17%.
Neurocrine Biosciences Operating Margin from 2020 to 2024
-
Value:-
NBIX Operating Margin History by year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 0.21% | 25.08% |
| 2022 | 0.17% | -8.76% |
| 2021 | 0.18% | -41.45% |
| 2020 | 0.31% | - |
View the highest operating margin companies 
